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The present investigation was designed to examine the effect of bilateral
lesions of the caudate nuclei, the effects of a psychotonic drug Piracetam and
cyclophosphamide, on survival and incidence of metastases in tumor-bearing
rats. We used 102 Wistar rats. The tumors were induced by 3-methylcholan-
threne. After surgical extirpation of the tumors, animals were treated with
bilateral lesions of the caudate nuclei, the psychoactive drug piracetam,
cyclophosphamide or nothing. Autopsy and histological examinations were
performed in all animals. Rats with bilateral lesions of the caudate nuclei
(12.5%) survived over 120 days vs. 81.2% from the piracetam group, 68.8%
from the cyclophosphamide group and 50% of the control group. All animals
with bilateral lesions of the caudate nuclei had metastases, whereas in the
piracetam group no animals had metastases. In the cyclophosphamide group
45.4% of the animals was without metastases and in control group 27.3% of
the animals was without metastases. The mechanism of the antineoplastic
effect monoamine stimulator, included the interaction of influences both on
the metabolism of the CNS and of tumor. Most probably, the neurotransmit-
ter modulation exerted an influence on cancerogenesis not only by regula-
tion/deregulation of brain homeostasis, but also via a direct effect on intracel-
lular processes during cell development and differentiation. Our results indi-
cate that increased monoamine level in the brain supports adaptive homeo-
static mechanisms, which are among other responsible for the suppression
of cancerogenesis.
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In our practice of Ca ovarii mainly postoperative chemotherapy has been
applied although according to our protocole either chemotehrapy (CHT) or
radiotherapy  (RT) could be used. That is done in consonance with the gen-
eral trends in the world. Our practice reveals that the survival is not signifin-
cantly improved. So the aim of this invesstigation was to find out the best pos-
sible therapeutical modality. Two patient groups were investigated within the
prospective study in the following way. Two groups were selected by desease
stadiums. Groups included two series each (determinated by random selec-
tion).
I Ca ovarii IA - IIB (pelvis) (except IA - IB G  I)
1. Postoperative locoregional irradiation (pelvis) or
2. Postoperative chemotherapy (Cis. pl. + Endox) VI cycles
II Ca ovarii IIC - IIIC (FIGO)
1. Postoperative CHT (Car. pl. + Endox. VI cycles) or
2. Postoperative CHT (Car. pl. cycles.) + radiotherapy (RT abdomen-
bath + boost dose to the pelvis and paraaortal. lgl.
Ten patients (aged  from 43 to 74 years) were controlled and followed up.
All of them were in CII group because of the stadium of disease (stage III,
mostly).
Already mentioned therapy modalities were done. Histopathological type
was diagnosed as Adenocarcinoma. Preparation of patients for radiotherapy
and planning were conducted according to the optimal European and world
standards. In this stage of the research we evaluated the regression of the
postoperative rest tumor and only early irradiation sequelae and/postoperative
rest tumor regression or metastases (ascites, pleural effusion). In the period
of only three months it was not possible to give valid data about pa survival,
local relapse or metastatic disease. Preliminary results do not show the sig-
nificant difference between tumor, metastases regression in two series CI-1
and CI-2. Nausea, vomiting and hematogenic toxicity appeared more fre-
quently in the seria CII-2. The results obtained justify the continuation of this
treatment and follow-up of patients for at least two years. It would give the
opportunity to compare new parameters: last sequelae, patients' survival, and
appearance of local relapse or metastases.
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